Notice: Temporary Suspension of New Experiment Creation
We have temporarily disabled the creation of new experiments as we are continuously running out of space. This issue has been impacting both uploads and downloads from FlowRepository. By taking this step, we aim to make downloads of existing data more reliable.
We apologize for the inconvenience and appreciate your understanding as we work on upgrading our hardware and improving the overall solution.
Thank you for your patience.

Download-button_s

Experiment Overview

Repository ID: FR-FCM-Z6ZZ Experiment name: AMG232 and irradiation treatment of patient-derived GBM cell lines MIFlowCyt score: 56.00%
Primary researcher: Dena Panovska PI/manager: Frederik De Smet Uploaded by: Dena Panovska
Experiment dates: 2020-03-02 - 2020-03-04 Dataset uploaded: Dec 2022 Last updated: Dec 2023
Keywords: [glioblastoma] [predictive model] [functional diagnostics] Manuscripts:
Organizations: KU Leuven, Leuven, Vlaams Brabant (Belgium)
Purpose: Patient-derived GBM cell lines were acutely treated in vitro with AMG232 and radiotherapy (RT), after which we measured the changes in drug-relevant and GBM phenotypic markers between control and treated samples. In parallel, on the same cell line pool, we performed bulk cytotoxicity assays, where we tested the long-term survival of the cell lines. Finally, we used the expression changes of the protein markers and correlated them to the sensitivity profiles, to ultimately generate a predictive model.
Conclusion: As in the bulk dose-response assays, at the protein level, we saw that TP53 wild type cells were more sensitive to the therapies than TP53 mutant cells. However, there was heterogeneous response potential within the TP53 wild type pool. As such, we learned that drug-response markers induced upon drug treatment, an approach called functional diagnostics is more predictive of in vitro cell survival outcome, than baseline protein expression levels.
Comments: All samples were barcoded, pooled, stained and analysed in a single experiment.
Funding: Not disclosed
Quality control: Cytotoxicity Batch control samples of BT112 (TP53 wild type) sensitive cell line and BT245 (TP53 mutant) resistant cell line, were included in each analysis tube.


Experiment variables

Timepoints
· 8 hours AMG232 BT360_AMG232_8_S_3.fcs · LBT005_AMG232_8_S_2.fcs
· 16 hours AMG232 BT360_AMG232_16_S_3.fcs · LBT005_AMG232_16_S_2.fcs
· 24 hours AMG232 BT360_AMG232_24_S_3.fcs · LBT005_AMG232_24_S_2.fcs
· 48 hours AMG232 BT360_AMG232_48_S_3.fcs · LBT005_AMG232_48_S_2.fcs
· 8 hours RT BT360_RT_48_S_3.fcs · LBT005_RT_8_S_2.fcs
· 16 hours RT BT360_RT_16_S_3.fcs · LBT005_RT_16_S_2.fcs
· 24 hours RT BT360_RT_24_S_3.fcs · LBT005_RT_24_S_2.fcs
· 48 hours RT BT360_RT_8_S_3.fcs · LBT005_RT_48_S_2.fcs

Conditions
· Control 2080_Control_16_S_2.fcs · 5050_Control_16_S_2.fcs · 8020_Control_16_S_2.fcs · BT112_Control_0_Sample_2.fcs · BT112_Control_16_BC_1.fcs · BT112_Control_16_BC_2.fcs · BT112_Control_16_BC_3.fcs · BT245_Control_16_BC_1.fcs · BT245_Control_16_BC_2.fcs · BT245_Control_16_BC_3.fcs · BT245_Control_16_S_1.fcs · BT248_Control_16_S_3.fcs · BT320_Control_16_S_3.fcs · BT333_Control_16_S_3.fcs · BT360_Control_48_S_3.fcs · BT569_Control_16_S_2.fcs · LBT003_Control_16_S_1.fcs · LBT005_Control_16_S_2.fcs · LBT059_Control_16_S_3.fcs · LBT062_Control_16_S_3.fcs · LBT070_Control_0_Sample_1.fcs · LBT086_Control_16_S_3.fcs · LBT124_Control_16_S_3.fcs
· AMG232 2080_AMG232_16_S_2.fcs · 5050_AMG232_16_S_2.fcs · 8020_AMG232_16_S_2.fcs · BT112_AMG232_0_Sample_2.fcs · BT112_AMG232_16_BC_1.fcs · BT112_AMG232_16_BC_2.fcs · BT112_AMG232_16_BC_3.fcs · BT245_AMG232_16_BC_1.fcs · BT245_AMG232_16_BC_2.fcs · BT245_AMG232_16_BC_3.fcs · BT245_AMG232_16_S_1.fcs · BT248_AMG232_16_S_3.fcs · BT320_AMG232_16_S_3.fcs · BT333_AMG232_16_S_3.fcs · BT360_AMG232_16_S_3.fcs · BT360_AMG232_24_S_3.fcs · BT360_AMG232_48_S_3.fcs · BT360_AMG232_8_S_3.fcs · BT569_AMG232_16_S_2.fcs · LBT003_AMG232_16_S_1.fcs · LBT005_AMG232_16_S_2.fcs · LBT005_AMG232_24_S_2.fcs · LBT005_AMG232_48_S_2.fcs · LBT005_AMG232_8_S_2.fcs · LBT059_AMG232_16_S_3.fcs · LBT062_AMG232_16_S_3.fcs · LBT070_AMG232_0_Sample_1.fcs · LBT086_AMG232_16_S_3.fcs · LBT124_AMG232_16_S_3.fcs
· RT 2080_RT_16_S_2.fcs · 5050_RT_16_S_2.fcs · 8020_RT_16_S_2.fcs · BT112_RT_0_Sample_2.fcs · BT245_RT_16_S_1.fcs · BT248_RT_16_S_3.fcs · BT320_RT_16_S_3.fcs · BT333_RT_16_S_3.fcs · BT360_RT_16_S_3.fcs · BT360_RT_24_S_3.fcs · BT360_RT_48_S_3.fcs · BT360_RT_8_S_3.fcs · BT569_RT_16_S_2.fcs · LBT003_RT_16_S_1.fcs · LBT005_RT_16_S_2.fcs · LBT005_RT_24_S_2.fcs · LBT005_RT_48_S_2.fcs · LBT005_RT_8_S_2.fcs · LBT059_RT_16_S_3.fcs · LBT062_RT_16_S_3.fcs · LBT086_RT_16_S_3.fcs · LBT124_RT_16_S_3.fcs · PDCL_LBT070_RT_0_Sample-_2__viable-(1).fcs

Sample Type
· Mixes BT360 and BT333 - AMG232 2080_AMG232_16_S_2.fcs · 5050_AMG232_16_S_2.fcs · 8020_AMG232_16_S_2.fcs
· Mixes BT360 and BT333 - RT 2080_RT_16_S_2.fcs · 5050_RT_16_S_2.fcs · 8020_RT_16_S_2.fcs
· Mixes BT360 and BT333 - Controls 2080_Control_16_S_2.fcs · 5050_Control_16_S_2.fcs · 8020_Control_16_S_2.fcs
· Batch Controls BT112_AMG232_16_BC_1.fcs · BT112_AMG232_16_BC_2.fcs · BT112_AMG232_16_BC_3.fcs · BT112_Control_16_BC_1.fcs · BT112_Control_16_BC_2.fcs · BT112_Control_16_BC_3.fcs · BT245_AMG232_16_BC_1.fcs · BT245_AMG232_16_BC_2.fcs · BT245_AMG232_16_BC_3.fcs · BT245_Control_16_BC_1.fcs · BT245_Control_16_BC_2.fcs · BT245_Control_16_BC_3.fcs

Download FCS Files or login and see the dataset in your inbox for further annotation details.